Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Maybe they will post the shareholder meeting slide

Message Board Public Reply | Private Reply | Keep | Replies (3)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155577
(Total Views: 262)
Posted On: 05/28/2019 10:14:26 AM
Avatar
Posted By: trding
Re: misiu143 #3550
Maybe they will post the shareholder meeting slides as they have done in the past.

Not sure on these three:
1) TNBC ODD: With TNBC ODD, I know there has been some confusion. But the last I remember is NP saying there applied maybe 60-70 days ago and will be checking on it.
Since they are after MOA in many cancers, and there is preclinical data with ccr5 inhibitors with many cancers, I wonder if the FDA will deny ODD for TNBC because the potential market size is much bigger than 200k or if they will stick with just TNBC and say yes.

2) Animal Preclinical Trials Preliminary Data -- I have not seen an update if they have started. I believe NP said in the CC that Colon IND for Phase 2 is not based on this data, but previous data. So maybe they haven't started, as you would think that would be the first one.

3) Monotherapy: IncellDx Dose/CCR5 Analysis Results. I not remember hearing anything new.


So maybe (if we don't get a pr this week), just to get discussion for June milestones started.

June

TNBC Phase 2 Trial: First Three Patients Injected at 350mg (stage 1 of 3+3)
Mono pivotal phase 3 trial FDA's response
Initiate mono pivotal phase 3 (on their list of milestones for June, but maybe July)
TO closes
FDA response to allow 525mg safety data with Combo
BLA Part 2 possible (with FDA approval of 525mg) June-July
Colon Cancer Phase 2 Trial IND Submission
Results from NASH mice study (possible but not certain)
Convertible note paid A BIG ONE (alps is dropping shares again this morning)
ASM Microbe 2019 June 21st
Prostate Cancer Test 510(k) filing








(1)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us